Tools for advancing maternal, newborn, and child health advocacy and accountability from subnational to global levels

PATH Kenya is exited to invite you to “Tools for advancing maternal, newborn, and child health (MNCH) advocacy and accountability from subnational to global levels,” the second in their series of Africa regional MNCH advocacy dialogues. 

Part 1
Date: Thursday, 27 June, 2024
Time: 15:00-16:30 EAT | 14:00-15:30 CAT/CEST | 13:00-14:30 WAT | 8:00-9:30 EDT

REGISTER FOR PART 1

As the world approaches critical global health milestones, African countries led the way on a resolution passed during the 77th World Health Assembly to accelerate progress on reducing maternal, newborn, and child mortality.

It is essential that all commitments are kept and progress is realized, but to do so we must overcome the key challenge of effectively tracking these commitments and translating them into actionable outcomes. In this session, PATH will highlight tools advocates can use at all levels to inform and enhance their work.

Session objectives: 

• Understand different tools for advancing MNCH-related advocacy and accountability from subnational to global levels.
• Strengthen alignment on advocacy priorities and coordination of advocacy partners in Africa to improve MNCH outcomes across the continent.

This dialogue will be split across two sessions with each covering different tools available to support MNCH advocacy.

If you have any questions or need further information, contact Pasqueline Njau (panjau@path.org) or Rebecca Mwima (rmwima@path.org).

Join us for the BARDA VITAL Global Health Security Symposium at the Rahel Hirsch Center for Translational Medicine in Berlin — an exciting event focused on visionary advancements in pandemic preparedness and response, vaccine and therapeutics innovation, and medical countermeasures aimed at enhancing pandemic preparedness and response for a safer future.

This dynamic symposium features invaluable networking opportunity, inspiring talks, and exciting company pitches. Connect with leading experts, researchers, and professionals from both sides of the Atlantic to explore the latest discoveries and strategies in preventing and addressing global health crises.

Join us for this engaging and insightful event that brings together key stakeholders in healthcare and innovation. Whether you're a startup, academic institution, or industry expert, this symposium invites you to explore cutting-edge solutions and connect with members of the U.S. and EU therapeutics and vaccine innovation community.

In healthcare, GenAI holds immense promise for revolutionizing medical research, diagnosis and treatment. But how can GenAI be utilized in the case of Real-World Evidence (RWE)? And to what extent can one leverage this technology effectively to enhance trial efficiency, improve data analysis capabilities and drive meaningful discoveries?

In our Climedo Connect on June 27, 2024, Dragan Mileski (Co-Founder and CTO of Climedo) will explore how to meaningfully apply GenAI across the field of clinical trials, with a specific focus on RWE. 

What to expect: 

• Understanding GenAI: Explore the fundamentals of GenAI, including emerging trends and technology outlook, to grasp its potential in transforming RWE studies.
• Top use cases for GenAI in post-market studies: Dive into the practical applications of GenAI in post-market studies, examining its role in drug safety monitoring, comparative effectiveness analysis and more.
• Best practices for incorporating GenAI in clinical research: Learn actionable strategies and best practices for seamlessly integrating GenAI into your trials. 

Don't miss this opportunity to gain valuable insights and contribute to the discussion on enhancing collaboration between trial physicians, sponsors, and CROs in clinical trials.